HUP0103108A2 - Formoterolt és budesonidot tartalmazó készítmény alkalmazása asztma akut állapotának megelőzésére - Google Patents
Formoterolt és budesonidot tartalmazó készítmény alkalmazása asztma akut állapotának megelőzéséreInfo
- Publication number
- HUP0103108A2 HUP0103108A2 HU0103108A HUP0103108A HUP0103108A2 HU P0103108 A2 HUP0103108 A2 HU P0103108A2 HU 0103108 A HU0103108 A HU 0103108A HU P0103108 A HUP0103108 A HU P0103108A HU P0103108 A2 HUP0103108 A2 HU P0103108A2
- Authority
- HU
- Hungary
- Prior art keywords
- asthma
- formoterol
- budesonide
- prevention
- composition
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000001154 acute effect Effects 0.000 title 1
- 229940021598 formoterol and budesonide Drugs 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 1
- 208000024716 acute asthma Diseases 0.000 abstract 1
- 229960004436 budesonide Drugs 0.000 abstract 1
- 208000023819 chronic asthma Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002848 formoterol Drugs 0.000 abstract 1
- 230000000737 periodic effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Abstract
A találmány tárgya egy, szükség esetén a jellemző tünetek enyhítéséreszolgáló, (a) egy első hatóanyagként formoterol, gyógyszerészetilegelfogadható sója vagy szolvátja vagy ezen só egy szolvátja; és (b) egymásodik hatóanyagként budesonid keverékét tartalmazó készítmény asztmaakut állapotának és/vagy időszakos asztma és/vagy krónikus asztmaeseményeinek megelőzésére vagy kezelésére szolgáló, inhalációvalbeadható gyógyszer előállítására való alkalmazása képezi. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802073A SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | New use |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0103108A2 true HUP0103108A2 (hu) | 2002-05-29 |
HUP0103108A3 HUP0103108A3 (en) | 2002-11-28 |
Family
ID=20411658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0103108A HUP0103108A3 (en) | 1998-06-11 | 1999-06-10 | Use of composition comprising formoterol and budesonide for the prevention of an acute condition of asthma |
Country Status (35)
Country | Link |
---|---|
US (2) | US20010049396A1 (hu) |
EP (3) | EP1085877B1 (hu) |
JP (1) | JP2002517450A (hu) |
KR (1) | KR20010052721A (hu) |
CN (1) | CN100389771C (hu) |
AR (1) | AR018410A1 (hu) |
AT (1) | ATE389409T1 (hu) |
AU (1) | AU771715B2 (hu) |
BR (1) | BR9911073A (hu) |
CA (1) | CA2334411C (hu) |
CY (1) | CY1110376T1 (hu) |
CZ (1) | CZ300874B6 (hu) |
DE (1) | DE69938390T2 (hu) |
DK (1) | DK1085877T3 (hu) |
EE (1) | EE05661B1 (hu) |
ES (1) | ES2302384T3 (hu) |
HK (1) | HK1035145A1 (hu) |
HU (1) | HUP0103108A3 (hu) |
ID (1) | ID27937A (hu) |
IL (2) | IL139921A0 (hu) |
IS (1) | IS5752A (hu) |
MY (1) | MY129281A (hu) |
NO (3) | NO20006253L (hu) |
NZ (1) | NZ536279A (hu) |
PL (1) | PL344665A1 (hu) |
PT (1) | PT1085877E (hu) |
RU (1) | RU2222332C2 (hu) |
SA (1) | SA99200234B1 (hu) |
SE (1) | SE9802073D0 (hu) |
SK (1) | SK286252B6 (hu) |
TR (1) | TR200003666T2 (hu) |
TW (1) | TWI252756B (hu) |
UA (1) | UA87956C2 (hu) |
WO (1) | WO1999064014A1 (hu) |
ZA (1) | ZA200006943B (hu) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
GB0009584D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
GB0012261D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
GB0012260D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
ME00220B (me) | 2000-05-22 | 2010-10-10 | Chiesi Farm Spa | Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom |
TR200401980T4 (tr) | 2001-07-02 | 2004-09-21 | Chiesi Farmaceutici S.P.A. | Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
EP1446104B2 (en) * | 2001-11-01 | 2011-08-03 | Novartis AG | Spray drying methods |
FI20020126A0 (fi) * | 2002-01-23 | 2002-01-23 | Orion Corp | Koostumuksia pulmonaaliseen antoon |
SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
GB0219512D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions with high drug ratios |
GB0219511D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
JP4744876B2 (ja) * | 2002-08-21 | 2011-08-10 | ノートン・ヘルスケアー リミテッド | 乾燥粉末吸入組成物の製造方法 |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
US20050207983A1 (en) | 2004-03-05 | 2005-09-22 | Pulmatrix, Inc. | Formulations decreasing particle exhalation |
US20070098644A1 (en) * | 2005-10-31 | 2007-05-03 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
KR20090129998A (ko) | 2007-02-11 | 2009-12-17 | 맵 파마슈티컬스, 인코포레이티드 | 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 dhe의 치료적 투여 방법 |
EP2124915A2 (en) | 2007-02-19 | 2009-12-02 | Cipla Limited | Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid |
EP1982709A1 (en) * | 2007-04-19 | 2008-10-22 | CHIESI FARMACEUTICI S.p.A. | Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma |
CN107412212B (zh) | 2009-05-29 | 2021-01-22 | 珍珠治疗公司 | 经肺递送长效毒蕈碱拮抗剂及长效β2肾上腺素能受体激动剂的组合物及相关方法与系统 |
PL2538922T3 (pl) * | 2010-02-25 | 2016-11-30 | Formułowanie kompozycji do leczenia stanów zapalnych | |
WO2012007729A2 (en) * | 2010-07-16 | 2012-01-19 | Cipla Limited | Pharmaceutical compositions |
EP2448571B1 (en) | 2010-08-30 | 2013-06-12 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
EP2611438B1 (en) | 2010-08-30 | 2020-04-01 | Pulmatrix Operating Company, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
CN102416179B (zh) | 2010-09-28 | 2014-05-07 | 益得生物科技股份有限公司 | 用于哮喘的吸入性复方组合物 |
DK3470057T3 (da) | 2010-09-29 | 2021-11-22 | Pulmatrix Operating Co Inc | Kationiske tørpulvere omfattende magnesiumsalt |
MX354828B (es) | 2010-09-29 | 2018-03-22 | Pulmatrix Operating Co Inc | Polvos secos de cationes metálicos monovalentes para inhalación. |
JOP20120023B1 (ar) * | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
CN107596518B (zh) | 2012-02-29 | 2021-04-23 | 普马特里克斯营业公司 | 可吸入干粉剂 |
RU2504382C1 (ru) * | 2012-06-13 | 2014-01-20 | Шолекс Девелопмент Гмбх | Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения |
WO2014165303A1 (en) | 2013-04-01 | 2014-10-09 | Pulmatrix, Inc. | Tiotropium dry powders |
ITMI20130571A1 (it) | 2013-04-10 | 2014-10-11 | Zambon Spa | Composizione farmaceutica contenente budesonide e formoterolo |
GB201408387D0 (en) * | 2014-05-12 | 2014-06-25 | Teva Pharmaceuticals Europ B V | Treatment of respiratory disorders |
TW201735914A (zh) * | 2015-12-22 | 2017-10-16 | 阿斯特捷利康公司 | 用於治療慢性阻塞性肺疾病之醫藥組成物 |
IT202000006442A1 (it) | 2020-03-27 | 2021-09-27 | Genetic S P A | Budesonide 21-phosphate salts and pharmaceutical compositions containing the same |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4203401A (en) | 1979-01-29 | 1980-05-20 | General Motors Corporation | Evaporative emissions canister |
DK0416950T3 (da) | 1989-09-08 | 1993-10-11 | Glaxo Group Ltd | Medikamenter |
IL95590A (en) | 1989-09-08 | 1996-06-18 | Glaxo Group Ltd | Medicinal preparations containing Salmetrol and Pluticasone Propionate |
US5250286A (en) * | 1990-05-07 | 1993-10-05 | Aegis Technology, Inc. | Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline |
PL164294B1 (pl) | 1990-12-20 | 1994-07-29 | Inst Farmaceutyczny | Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL |
US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
US5119791A (en) | 1991-06-07 | 1992-06-09 | General Motors Corporation | Vapor storage canister with liquid trap |
US5444521A (en) | 1991-07-15 | 1995-08-22 | Canon Kabushiki Kaisha | Image fixing device capable of controlling heating overshoot |
AU673660C (en) * | 1991-12-18 | 2002-07-25 | Astrazeneca Ab | New combination of formoterol and budesonide |
EP1086697A2 (en) | 1991-12-18 | 2001-03-28 | AstraZeneca AB | New combination of formoterol and budesonide |
US5408977A (en) | 1993-08-23 | 1995-04-25 | Walbro Corporation | Fuel tank with carbon canister and shut-off valve |
BR9407686A (pt) | 1993-10-01 | 1997-02-04 | Astra Ab | Processo e aparelho para o tratamento de um medicamento em pó finamente dividido uso do aparelho e aglomerados |
SE9404080L (sv) * | 1993-12-28 | 1995-06-29 | Ciba Geigy Ag | Förfarande för framställning av en optiskt ren enantiomer av formoterol |
US5511957A (en) | 1994-09-27 | 1996-04-30 | Walbro Corporation | High capacity fuel pump and filter combination |
SE9700134D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
US5983956A (en) * | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
GB9519692D0 (en) * | 1995-09-27 | 1995-11-29 | Quillin Helen | Atomising nozzle |
US6277862B1 (en) | 1995-11-24 | 2001-08-21 | Smithkline Beecham S.P.A. | Quinoline derivatives |
US5651349A (en) | 1995-12-11 | 1997-07-29 | Chrysler Corporation | Purge system flow monitor and method |
SE9603669D0 (sv) | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
SK184799A3 (en) | 1997-06-27 | 2000-06-12 | Astra Ab | New combination of antiasthma medicaments |
SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
US5957114A (en) | 1998-07-17 | 1999-09-28 | Ford Motor Company | Evaporative emission canister for an automotive vehicle |
US5924410A (en) | 1998-07-20 | 1999-07-20 | Ford Motor Company | Evaporative emission canister for an automotive vehicle |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6004537A (en) | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
US6227862B1 (en) * | 1999-02-12 | 2001-05-08 | Advanced Drivers Education Products And Training, Inc. | Driver training system |
DE60016990T2 (de) | 1999-02-26 | 2005-12-29 | Walbro Corp., Cass City | Fahrzeugbrennstoffsystem |
SE9900834D0 (sv) | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
US6237574B1 (en) | 1999-04-20 | 2001-05-29 | Ford Motor Company | Evaporative emission canister for an automotive vehicle |
US6136075A (en) | 1999-05-03 | 2000-10-24 | Westvaco Corporation | Automotive evaporative emissions canister adsorptive restraint system |
JP3646217B2 (ja) | 1999-07-08 | 2005-05-11 | 愛三工業株式会社 | キャニスタモジュール |
US6374811B1 (en) | 2000-10-04 | 2002-04-23 | Ford Global Technologies, Inc. | System and method for minimizing fuel evaporative emissions from an internal combustion engine |
-
1998
- 1998-06-11 SE SE9802073A patent/SE9802073D0/xx unknown
-
1999
- 1999-05-28 AR ARP990102532A patent/AR018410A1/es unknown
- 1999-06-01 TW TW088109070A patent/TWI252756B/zh not_active IP Right Cessation
- 1999-06-09 SA SA99200234A patent/SA99200234B1/ar unknown
- 1999-06-09 MY MYPI99002351A patent/MY129281A/en unknown
- 1999-06-10 DK DK99930103T patent/DK1085877T3/da active
- 1999-06-10 UA UA2000126983A patent/UA87956C2/uk unknown
- 1999-06-10 KR KR1020007013993A patent/KR20010052721A/ko not_active Application Discontinuation
- 1999-06-10 CN CNB998072303A patent/CN100389771C/zh not_active Expired - Lifetime
- 1999-06-10 TR TR2000/03666T patent/TR200003666T2/xx unknown
- 1999-06-10 DE DE69938390T patent/DE69938390T2/de not_active Expired - Lifetime
- 1999-06-10 PL PL99344665A patent/PL344665A1/xx unknown
- 1999-06-10 ES ES99930103T patent/ES2302384T3/es not_active Expired - Lifetime
- 1999-06-10 SK SK1888-2000A patent/SK286252B6/sk not_active IP Right Cessation
- 1999-06-10 PT PT99930103T patent/PT1085877E/pt unknown
- 1999-06-10 US US09/367,950 patent/US20010049396A1/en not_active Abandoned
- 1999-06-10 AT AT99930103T patent/ATE389409T1/de active
- 1999-06-10 BR BR9911073-3A patent/BR9911073A/pt not_active Application Discontinuation
- 1999-06-10 EP EP99930103A patent/EP1085877B1/en not_active Revoked
- 1999-06-10 CZ CZ20004593A patent/CZ300874B6/cs not_active IP Right Cessation
- 1999-06-10 ID IDW20002566A patent/ID27937A/id unknown
- 1999-06-10 CA CA002334411A patent/CA2334411C/en not_active Expired - Lifetime
- 1999-06-10 EP EP03002381A patent/EP1316311A1/en not_active Withdrawn
- 1999-06-10 HU HU0103108A patent/HUP0103108A3/hu unknown
- 1999-06-10 AU AU46710/99A patent/AU771715B2/en not_active Expired
- 1999-06-10 NZ NZ536279A patent/NZ536279A/en not_active IP Right Cessation
- 1999-06-10 IL IL13992199A patent/IL139921A0/xx active IP Right Grant
- 1999-06-10 JP JP2000553082A patent/JP2002517450A/ja active Pending
- 1999-06-10 WO PCT/SE1999/001031 patent/WO1999064014A1/en not_active Application Discontinuation
- 1999-06-10 RU RU2000131218/14A patent/RU2222332C2/ru not_active IP Right Cessation
- 1999-06-10 EE EEP200000740A patent/EE05661B1/xx unknown
- 1999-06-10 EP EP10178172A patent/EP2266574A1/en not_active Withdrawn
-
2000
- 2000-11-27 ZA ZA200006943A patent/ZA200006943B/en unknown
- 2000-11-27 IL IL139921A patent/IL139921A/en not_active IP Right Cessation
- 2000-12-05 IS IS5752A patent/IS5752A/is unknown
- 2000-12-08 NO NO20006253A patent/NO20006253L/no not_active Application Discontinuation
-
2001
- 2001-08-17 HK HK01105814A patent/HK1035145A1/xx not_active IP Right Cessation
-
2003
- 2003-09-19 US US10/665,240 patent/US9295644B2/en active Active
-
2008
- 2008-05-13 CY CY20081100507T patent/CY1110376T1/el unknown
-
2013
- 2013-02-18 NO NO20130269A patent/NO20130269L/no not_active Application Discontinuation
-
2014
- 2014-06-27 NO NO20140823A patent/NO20140823L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103108A2 (hu) | Formoterolt és budesonidot tartalmazó készítmény alkalmazása asztma akut állapotának megelőzésére | |
HUP0003848A2 (hu) | Budesonid és formoterol új alkalmazása | |
HUP0203176A2 (hu) | Szimetikont tartalmazó orális, szilárd adagolási forma | |
HUP0302571A2 (hu) | Szerves vegyületek keverékét tartalmazó gyógyszerkészítmény légúti betegségek kezelésére | |
HUP0301868A2 (hu) | Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz | |
WO2021207409A3 (en) | Small molecule inhibitors of sars-cov-2 viral replication and uses thereof | |
HUP0401614A2 (hu) | PDE4 inhibitort és antikolinerg hatóanyagot tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0203728A2 (hu) | Formoterolt tartalmazó aeroszolkészítmény | |
HUP0401998A2 (hu) | PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető | |
HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
BR0008699A (pt) | Combinações de formoterol e furoato demometasona para asma | |
HUP0402075A2 (hu) | Készítmények nátha kezelésére | |
HUP0002316A2 (hu) | Gyorsan olvadó orális adagolási formák | |
SI9200403B (en) | New combination of a bronchodilator and a steroidal antiinflammatory drug for treatment of respiratory disorders as well as its use and preparation thereof | |
HUP0202862A2 (hu) | A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény | |
HUP0102365A2 (hu) | Lipofil glükokortikoszteroidot és csak egy felületaktív anyagot tartalmazó micellákból álló gyógyszerkészítmények, valamint eljárás előállításukra | |
HUP0101411A2 (hu) | 2-es típusú angiotenzin II receptor agonistákat tartalmazó gyógyszerkészítmények és ezek alkalmazása | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
TNSN04048A1 (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
HUP0004363A2 (hu) | Miltefosint tartalmazó orális szilárd gyógyszerkészítmények leishmaniasis kezelésére | |
HUP0400222A2 (hu) | PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására | |
UA42719C2 (uk) | Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб | |
WO2001076601A3 (en) | Pharmaceutical compositions comprising salmeterol and ipratropium | |
JP2005508963A5 (hu) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |